Closed-blood Sampling Devices in the Adult Critically Ill Patient

Launched by UNIVERSITY OF BARCELONA · Jun 21, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new way to collect blood samples from critically ill adult patients in the Intensive Care Unit (ICU). The researchers want to see if using special Closed-Blood Sampling Devices (CSBD) can reduce the amount of blood drawn for tests compared to the usual method, which often wastes blood. They will look at how many red blood cells are given to patients and any problems related to the use of the blood collection devices during their stay in the ICU, which can last up to 21 days.

To be eligible for this study, patients must be adults who have an arterial catheter in place and are expected to stay in the ICU for at least 24 hours, with an additional 72 hours needed for the study. Some patients, such as those with certain medical conditions or who are pregnant, may not be able to participate. If a patient decides to join the study, they can expect to be monitored closely for any issues while using the new blood sampling devices. The trial is not yet recruiting participants, but it aims to improve the care and comfort of patients in critical condition.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult patients with an arterial catheter who agree to participate in the study, with a stay in the ICU of 24h and a minimum of 72h more with an arterial catheter
• • Non-inclusion criteria: Therapeutic Limitation of Life Support, Jehovah's Witnesses.
• Exclusion Criteria:
• • Patients with chronic renal failure
• • Patients with active gastrointestinal bleeding
• • Patients diagnosed with hematologic cancer
• • Women with menstruation at the time of admission
• • Pregnant women
• • Withdrawal criteria: presence of active gastrointestinal bleeding during the study inclusion period.